Becton Dickinson Blood Specimen Collection Portfolio – supply disruption

Document first published:
Page updated:
Topic:
Publication type:

We have been notified of a supply disruption in relation to Becton Dickinson (BD) on their Blood Specimen Collection Portfolio. Details of the products impacted and the demand management measures in place are included in the Important Customer Notice, issued by NHS Supply Chain.

Summary

Published 8 October 2021.

Letter from Professor Stephen Powis, Mark Cubbon and Dr Nikita Kanani.

Summary

Published 16 September 2021.

Letter from Professor Stephen Powis, Mark Cubbon and Dr Nikita Kanani.

Summary

Published 26 August 2021.

Letter from Professor Stephen Powis, Mark Cubbon and Dr Nikita Kanani.

Summary

Published 10 August 2021.

Recommended actions for medical directors, nursing directors, GPs and pathology laboratories to optimise resources for pathology laboratory work.

In light of global shortages of blood tube products (not just those from BD), this guidance applies to every site regardless of system being used in order to balance demand.